Skip to main content
BioCatch logo

BioCatch

Updated Mar 24, 2026

Everything you need to know about BioCatch — from their $213M in funding to who's backing them.

🇮🇱IsraelSeries DAI Security

Out of 100

🇮🇱

HQ

Israel

🗓

Founded

2011

💰

Raised

$213M

🏷️

Stage

Series D

👥

Team

100-500

BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes

Is this your company? Claim it →

Key Facts

  • BioCatch is valued at $1.3B as of March 2026.
  • BioCatch has raised a total of $213M in disclosed funding across 1 funding rounds.
  • BioCatch was founded in 2011 by Avi Turgeman and is headquartered in Israel.
  • BioCatch employs approximately 100-500 people.
  • BioCatch operates in the AI Security category and is currently at the Series D stage.
  • BioCatch has an Awaira Score of 80/100, ranking it among the highly notable AI companies on Awaira.
  • BioCatch's most recent funding round was a Series C of $40M closed in March 2020, led by Bain Capital Ventures.

Source: Awaira · Updated Mar 24, 2026

$1.3B

Post-money

$213M

All rounds

80/100

2011

100-500 employees

Strengths

Unicorn status with $1.3B valuation

Elite Awaira Score of 80/100

Large team of 100-500+ employees

Analysis based on publicly available data. Not investment advice.

⚠️ ESTIMATE
💵Est. Annual Revenue
$50M–$500M estimated ARR

Awaira estimate based on public data. Not financial advice.

How does BioCatch stack up against competitors?

MetricBioCatchSocureWizAnduril
Awaira Score80/10095/10095/10092/100
Total Raised$213M$750M$1.9B$8.2B
Valuation$1.3B$4.5B$32B$30.5B
StageSeries DSeries EAcquiredSeries G
Founded2011201220202017
Employees100-500500-100012504,000
Country🇮🇱🇺🇸🇮🇱🇺🇸
A

Avi Turgeman

Founder & CEO

View founder profile →
StageSeries D
Employees100-500
Country🇮🇱 Israel
Connect
Bain Capital VenturesAmerican Express Ventures
Inactive
1 round
Series CLatest

Led by Bain Capital Ventures

$40M

Mar 2020

Frequently Asked Questions

What is BioCatch's valuation?
Based on the most recent funding round, the valuation sits at $1.3B.
Who invested in BioCatch?
Known backers include Bain Capital Ventures, American Express Ventures. These investors have supported the company through various funding rounds.
When did BioCatch last raise funding?
A Series C of $40M represents the most recent capital raise in March 2020. The round was led by Bain Capital Ventures.
How many employees does BioCatch have?
The team is roughly 100-500 people, headquartered in Israel.
What does BioCatch do?
BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes behavioural signals from hundreds of millions of user sessions monthly, building individual profiles that flag deviations indicating fraud. Founded in 2011, BioCatch is categorized under AI Security.
Who founded BioCatch?
Avi Turgeman established the company in 2011. It's based in Israel. Avi Turgeman serves as Founder & CEO.
Is BioCatch profitable?
Profitability details aren't publicly disclosed. The company has raised $213M in total funding and is currently at the Series D stage.
Where is BioCatch headquartered?
Headquarters are in Israel 🇮🇱. The company operates in the AI Security sector and was established in 2011.
⚔️

Compare BioCatch

See how BioCatch stacks up against competitors in valuation, funding, team size, and Awaira Score.

Browse all comparisons →